Achillion Pharmaceuticals, Inc. · New Haven, CT United States · (NASDAQ (GM): ACHN)
Company Description
More Companies in: New Haven, Connecticut
More Companies in These Related Industries: Pharmaceutical Preparation Mfg
View Achillion Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Achillion Pharmaceuticals is looking for the Achilles heel of infectious disease. The firm is developing biopharmaceutical treatments for infectious diseases, including antiviral treatments for HIV infection and hepatitis C, as well as antibacterials for fighting drug-resistant hospital-based infections. Lead candidate elvucitabine is in clinical trials for the treatment of HIV; the drug is designed specifically for patients who have become resistant to existing antiviral drugs. Achillion is working in collaboration with biotech firm Gilead Sciences to develop a possible treatment for chronic hepatitis C. Another candidate in development is aimed at combating staph and other drug-resistant infections. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Achillion Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Achillion Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (GM): ACHN Single Location |
| Fiscal Year-End | December |
| 2009 Employees | 43 |
Achillion Pharmaceuticals, Inc. Executives
23 executives listed for Achillion Pharmaceuticals, Inc.'s New Haven, CT location.
| Title | Name & Bio | Contact |
| Chairman | David Scheer | |
| President, CEO, and Director | Michael Kishbauch | |
| VP and CFO | Mary Kay Fenton |
Competition
Competitive Landscape for Achillion Pharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Achillion Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!